Citations

Showing 10 of 108119 citations.

TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy
Alquezar, Carolina , Schoch, Kathleen M. , Geier, Ethan G., Ramos, Eliana Marisa , Scrivo, Aurora , Li, Kathy H., Argouarch, Andrea R. , Mlynarski, Elisabeth E. , Dombroski, Beth A. , DeTure, Michael , Yokoyama, Jennifer S. , Burlingame, Alma L. , Schellenberg, Gerard D. , Miller, Timothy M. , Miller, Bruce L. , Dombroski, Beth , Dickson, Dennis W , Cuervo, Ana M , Burlingame, Alma L , Schellenberg, Gerard D , Miller, Timothy M , Miller, Bruce L , Kao, Aimee W. , DeTure, Michael , Yokoyama, Jennifer , Alquezar, Carolina , Dickson, Dennis W.

Mayo Clinic

Science Advances | November 5, 2021 | Volume: 7 | Issue: 45 | Pages: No page available

10.1126/sciadv.abg3897 | PMID 34739309 Get It

TSC1/hamartin haploinsufficiency increases risk for tauopathy by promoting tau acetylation and accumulation.
Feto-Maternal Outcomes of Breastfeeding during Pregnancy: A Systematic Review and Meta-Analysis
Ghozy, Sherief , Hashan, Mohammad Rashidul , Linh, Le Khac , Abdelrahman, Sara Attia Mahmoud , Tran, Quynh Thuy Huong , Quan, Nguyen Khoi , Le, Tran , Ibrahim, Hassan Yousif, El-Nile, Mohamed Omar, Kamel, Ahmed Mostafa Ahmed , Huy, Nguyen Tien , Giang, Hoang Thi Nam , Huy, Nguyen Tien , Ghozy, Sherief , Minh, Le Huu Nhat , Tawfik, Gehad Mohamed , Nam, Nguyen Hai

Mayo Clinic

Journal of Tropical Pediatrics | November 5, 2021 | Volume: 67 | Issue: 6 | Pages: No page available

10.1093/tropej/fmab097 | PMID 34962568 Get It

Abstract Background Breastfeeding is beneficial to both mother and infant. However, overlap of lactation with pregnancy and short recuperative intervals may impact mothers nutritionally. We aimed to investigate the possible effects of pregnancy during breastfeeding. Methods In October 2018, we searched systematically in nine electronic databases to investigate any association of breastfeeding during pregnancy with fetal and/or maternal outcomes. The study protocol was registered in PROSPERO (CRD41017056490). A meta-analysis was done to detect maternal and fetal outcomes and complications during pregnancy. Quality assessment was performed using the Australian Cancer Council bias tool for included studies. Results With 1992 studies initially identified, eight were eligible for qualitative analysis and 12 for quantitative analysis. Our results showed no significant difference in different abortion subtypes between lactating and non-lactating ones. In delivery, no difference between two groups regarding the time of delivery in full-term healthy, preterm delivery and preterm labor. No significant difference was detected in rates of antepartum, postpartum hemorrhage and prolonged labor between two groups. The women with short reproductive intervals may have higher supplemental intake and greater reduction fat store. The present studies showed that breastfeeding during pregnancy does not lead to adverse outcomes in the mother and her fetus in normal low-risk pregnancy, although it may lead to the nutritional burden on the mother. Conclusion The present studies showed that breastfeeding during pregnancy did not lead to the adverse outcomes in the mother and her fetus.
How Your Writing Can Succeed: Getting a Manuscript Accepted by The American Journal of Gastroenterology
Longstreth, George F. , Patton, Heather , Lacy, Brian E.

Mayo Clinic

American Journal of Gastroenterology | November 5, 2021 | Volume: 117 | Issue: 1 | Pages: 11-15

10.14309/ajg.0000000000001552 | PMID 34738549 Get It

Correction to: Pain Experience in Pancreatitis: Strong Association of Genetic Risk Loci for Anxiety and PTSD in Patients With Severe, Constant, and Constant-Severe Pain
Dunbar, Ellyn, Alkaade, Samer, Banks, Peter A. , Conwell, Darwin L. , Forsmark, Christopher E., Gardner, Timothy B. , Guda, Nalini M. , Machicado, Jorge D. , Muniraj, Thiruvengadam , Romagnuolo, Joseph , Sandhu, Bimaljit S., Sherman, Stuart , Slivka, Adam, Wilcox, C. Mel , Yadav, Dhiraj , Lewis, Michele D. , Greer, Phil J. , Amann, Stephen T. , Brand, Randall E. , Papachristou, Georgios I. , Whitcomb, David C.

Mayo Clinic

American Journal of Gastroenterology | November 5, 2021 | Volume: 117 | Issue: 2 | Pages: 359-359

10.14309/ajg.0000000000001549 | PMID 34738548 Get It

Detection of a Cryptic KMT2A/AFDN Gene Fusion [ins(6;11)(q27;q23q23)] in a Pediatric Patient with Newly Diagnosed Acute Myeloid Leukemia
Berg, Holly , Greipp, Patricia T. , Falcon, Corey , Jackson, Courtney C., Peterson, Jess F. , Berg, Holly E, Peterson, Jess F , Greipp, Patricia T , Baughn, Linda B.

Mayo Clinic

Laboratory Medicine | November 5, 2021 | Volume: 53 | Issue: 4 | Pages: e95-e99

10.1093/labmed/lmab109 | PMID 34894139 Get It

Abstract KMT2A gene rearrangements are a major oncogenic driver in multiple hematologic neoplasms. Apart from t(9;11)(p21;q23) (KMT2A/MLLT3) in acute myeloid leukemia (AML), KMT2A gene rearrangements are considered to convey high risk and poor overall survival. Herein, we report a case of a 7 year old boy with newly diagnosed AML and a cryptic KMT2A/AFDN gene fusion resulting from a 5′KMT2A insertional event. The results of conventional chromosome studies revealed trisomy 8 in all 20 metaphases, with normal-appearing chromosomes 6 and 11. A KMT2A break-apart FISH probe identified 2 intact copies of the KMT2A gene region and an extra 5′KMT2A signal in 85% of interphase nuclei. Subsequent FISH studies using a KMT2A/AFDN dual-color dual-fusion FISH probe revealed positive results for a single fusion in 82% of interphase nuclei, indicating a KMT2A/AFDN gene fusion. Subsequently, metaphase FISH confirmed the location of the KMT2A/AFDN fusion at 6q27. To our knowledge, this represents only the second time in the literature that a cryptic KMT2A/AFDN gene fusion resulting from a 5′KMT2A insertional event was reported.
Molecular and Pathology Features of Colorectal Tumors and Patient Outcomes Are Associated with Fusobacterium nucleatum and Its Subspecies animalis
Borozan, Ivan , Zaidi, Syed Hassan Ejaz , Harrison, Tabitha A. , Phipps, Amanda I. , Zheng, Jiayin , Lee, Stephen Dongsoo , Trinh, Quang M. , Steinfelder, Robert S. , Adams, Jeremy , Banbury, Barbara L. , Berndt, Sonja I. , Bullman, Susan , Cao, Yin , Figueiredo, Jane C. , Giannakis, Marios , Luo, Xuemei , Nishihara, Reiko , Papadopoulos, Nickolas , Reid, Emma , Thibodeau, Stephen N. , Harlid, Sophia , Gsur, Andrea , Gallinger, Steven, Ferretti, Vincent , Peters, Ulrike , Lee, Stephen , Brezina, Stefanie , Buchanan, Daniel D , Farris, Alton B , Figueiredo, Jane C , Mardis, Elaine R. , Harlid, Sophia , Um, Caroline Y , Hsu, Li , Gsur, Andrea , Campbell, Peter T , Ogino, Shuji , Sun, Wei , Hudson, Thomas J , Peters, Ulrike , Zheng, Yingye , Cao, Yin , Harrison, Tabitha A , Trinh, Quang M , Brezina, Stefanie , Buchanan, Daniel D. , Farris, Alton B. , Heisler, Lawrence E. , Hopper, John L. , Lin, Yi , Qu, Conghui , Reid, Emma E.G., Um, Caroline Y. , Campbell, Peter T. , Newcomb, Polly A. , Sun, Wei

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | November 4, 2021 | Volume: 31 | Issue: 1 | Pages: 210-220

10.1158/1055-9965.epi-21-0463 | PMID 34737207 Get It

Abstract Background: Fusobacterium nucleatum (F. nucleatum) activates oncogenic signaling pathways and induces inflammation to promote colorectal carcinogenesis. Methods: We characterized F. nucleatum and its subspecies in colorectal tumors and examined associations with tumor characteristics and colorectal cancer–specific survival. We conducted deep sequencing of nusA, nusG, and bacterial 16s rRNA genes in tumors from 1,994 patients with colorectal cancer and assessed associations between F. nucleatum presence and clinical characteristics, colorectal cancer–specific mortality, and somatic mutations. Results: F. nucleatum, which was present in 10.3% of tumors, was detected in a higher proportion of right-sided and advanced-stage tumors, particularly subspecies animalis. Presence of F. nucleatum was associated with higher colorectal cancer–specific mortality (HR, 1.97; P = 0.0004). This association was restricted to nonhypermutated, microsatellite-stable tumors (HR, 2.13; P = 0.0002) and those who received chemotherapy [HR, 1.92; confidence interval (CI), 1.07–3.45; P = 0.029). Only F. nucleatum subspecies animalis, the main subspecies detected (65.8%), was associated with colorectal cancer–specific mortality (HR, 2.16; P = 0.0016), subspecies vincentii and nucleatum were not (HR, 1.07; P = 0.86). Additional adjustment for tumor stage suggests that the effect of F. nucleatum on mortality is partly driven by a stage shift. Presence of F. nucleatum was associated with microsatellite instable tumors, tumors with POLE exonuclease domain mutations, and ERBB3 mutations, and suggestively associated with TP53 mutations. Conclusions: F. nucleatum, and particularly subspecies animalis, was associated with a higher colorectal cancer–specific mortality and specific somatic mutated genes. Impact: Our findings identify the F. nucleatum subspecies animalis as negatively impacting colorectal cancer mortality, which may occur through a stage shift and its effect on chemoresistance.
Blocking the Unbearable: The Case for the Erector Spinae Plane Block
Kandi, Lyndsay A. , Bruce, Marcus R. , Morozowich, Steven T., Casey, William J., Teven, Chad M.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | November 4, 2021 | Volume: 9 | Issue: 11 | Pages: e3915

10.1097/gox.0000000000003915 | PMID 34745803 Get It

The Obturator Fasciocutaneous Flap: A Novel Approach to Vulvovaginal Reconstruction
Kandi, Lyndsay A. , Teven, Chad M. , Hammond, Jacob B. , Lee, Raphael C.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | November 4, 2021 | Volume: 9 | Issue: 11 | Pages: e3914

10.1097/gox.0000000000003914 | PMID 34745802 Get It

Rethinking Global Health Education in Plastic Surgery Residency
Christie, B. , Kurnik, Nicole M. , Park, Eugene , Ranganathan, Kavitha , Smith, Anthony A.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | November 4, 2021 | Volume: 9 | Issue: 9 | Pages: e3775

10.1097/gox.0000000000003775 | PMID 34584823 Get It

Summary: Surgical disease is now among the most common, preventable, and growing contributors to the global burden of disease. The attitudes of trainees toward global surgery and the viability of a global surgery as an academic track have blossomed. More optimized experiences within residency education are necessary, however, to prepare the next generation of global surgeons. The field of plastic surgery is thus at an important crossroads in the effort to incorporate global surgery into training programs in a uniform fashion across the country. The recent American Council of Academic Plastic Surgeons meeting in February 2020 was dedicated to identifying strategies that will enhance the adoption of global surgery practices within plastic surgery. In this article, we discuss the principles, themes, and ideas that emerged from this session, and further develop concrete initiatives believed to be potentially fruitful. Some have been discussed in other surgical disciplines or presented in isolation to the plastic surgery community, but never as a cohesive set of recommendations that take into account the background and shortfalls of the current model for global health education in the 21st century. We then introduce five recommendations to optimize learner education: (1) clarification of learner expectations and roles; (2) domestic teaching for optimization of field experiences; (3) expansion of longitudinal, formal rotations; (4) strengthening of the role of research; and (5) integration of program financing.
Clinicopathologic models predicting non‐sentinel lymph node metastasis in cutaneous melanoma patients: Are they useful for patients with a single positive sentinel node?
Rentroia‐Pacheco, Barbara , Tjien-Fooh, Félicia , Quattrocchi, Enrica , Kobic, Ajdin, Wever, Renske , Bellomo, Domenico , Meves, Alexander , Hieken, Tina J. , Hieken, Tina J

Mayo Clinic

Journal of Surgical Oncology | November 4, 2021 | Volume: 125 | Issue: 3 | Pages: 516-524

10.1002/jso.26736 | PMID 34735719 Get It

AbstractBackground and ObjectivesOf clinically node‐negative (cN0) cutaneous melanoma patients with sentinel lymph node (SLN) metastasis, between 10% and 30% harbor additional metastases in non‐sentinel lymph nodes (NSLNs). Approximately 80% of SLN‐positive patients have a single positive SLN.MethodsTo assess whether state‐of‐the‐art clinicopathologic models predicting NSLN metastasis had adequate performance, we studied a single‐institution cohort of 143 patients with cN0 SLN‐positive primary melanoma who underwent subsequent completion lymph node dissection. We used sensitivity (SE) and positive predictive value (PPV) to characterize the ability of the models to identify patients at high risk for NSLN disease.ResultsAcross Stage III patients, all clinicopathologic models tested had comparable performances. The best performing model identified 52% of NSLN‐positive patients (SE = 52%, PPV = 37%). However, for the single SLN‐positive subgroup (78% of cohort), none of the models identified high‐risk patients (SE > 20%, PPV > 20%) irrespective of the chosen probability threshold used to define the binary risk labels. Thus, we designed a new model to identify high‐risk patients with a single positive SLN, which achieved a sensitivity of 49% (PPV = 26%).ConclusionFor the largest SLN‐positive subgroup, those with a single positive SLN, current model performance is inadequate. New approaches are needed to better estimate nodal disease burden of these patients.